Search for: "APP Pharmaceuticals, Inc." Results 261 - 280 of 414
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Aug 2011, 5:00 am by Bexis
App. 2007) (insurer bad faith) ($1,500,000); Jet Source Charter, Inc. v. [read post]
11 Aug 2011, 5:25 pm by FDABlog HPM
  As we previously reported, the statutory counterclaims provisions were recently asserted in the context of a 505(b)(2) application for Intelliject, Inc. [read post]
27 Jul 2011, 6:45 am by Cleve Clinton & Jamie Ribman
George Distributors, Inc., 950 S.W.2d 82 (Texas App-Amarillo 1997, _____). [read post]
20 Jul 2011, 1:27 pm by Bexis
Janssen Pharmaceuticals, Inc., 2011 WL 2640801, slip op. [read post]
10 Jul 2011, 11:29 pm by Gordon Johnson
The committee is seeking documents and information from Amphastar Pharmaceuticals, Momenta Pharmaceuticals, Siegfried USA Inc., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]
7 Jul 2011, 2:31 pm by Bexis
APP Pharmaceuticals, LLC, 2010 WL 4941451, at *4 (D.N.J. [read post]
24 Jun 2011, 11:19 pm by Apeng
(IP Think Tank) Nokia settles with Apple Inc on patent infringement claims and App Inc. is likely to pay huge copyright fee to Nokia / ?????????????????????????? [read post]
13 Jun 2011, 5:32 pm by FDABlog HPM
  Several other generic drug manufacturers submitted ANDAs to FDA containing Paragraph IV certifications to Orange Book-listed patents on GEMZAR, including APP Pharmaceuticals, Inc. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
16 May 2011, 8:08 pm by The Legal Blog
Justice KG BalakrishnanThe Supreme Court in Selvi & Ors. v State of Karnataka has examined the law relating to the involuntary administration of certain scientific techniques, namely narcoanalysis, polygraph examination and the Brain Electrical Activation Profile (BEAP) test for the purpose of improving investigation efforts in criminal cases. [read post]
7 Apr 2011, 1:16 pm by Bexis
Merrell–Dow Pharmaceuticals, Inc., 523 A.2d 374, 376-79 (Pa. [read post]